Literature DB >> 23467008

2D and 3D MALDI-imaging: conceptual strategies for visualization and data mining.

Herbert Thiele1, Stefan Heldmann, Dennis Trede, Jan Strehlow, Stefan Wirtz, Wolfgang Dreher, Judith Berger, Janina Oetjen, Jan Hendrik Kobarg, Bernd Fischer, Peter Maass.   

Abstract

3D imaging has a significant impact on many challenges in life sciences, because biology is a 3-dimensional phenomenon. Current 3D imaging-technologies (various types MRI, PET, SPECT) are labeled, i.e. they trace the localization of a specific compound in the body. In contrast, 3D MALDI mass spectrometry-imaging (MALDI-MSI) is a label-free method imaging the spatial distribution of molecular compounds. It complements 3D imaging labeled methods, immunohistochemistry, and genetics-based methods. However, 3D MALDI-MSI cannot tap its full potential due to the lack of statistical methods for analysis and interpretation of large and complex 3D datasets. To overcome this, we established a complete and robust 3D MALDI-MSI pipeline combined with efficient computational data analysis methods for 3D edge preserving image denoising, 3D spatial segmentation as well as finding colocalized m/z values, which will be reviewed here in detail. Furthermore, we explain, why the integration and correlation of the MALDI imaging data with other imaging modalities allows to enhance the interpretation of the molecular data and provides visualization of molecular patterns that may otherwise not be apparent. Therefore, a 3D data acquisition workflow is described generating a set of 3 different dimensional images representing the same anatomies. First, an in-vitro MRI measurement is performed which results in a three-dimensional image modality representing the 3D structure of the measured object. After sectioning the 3D object into N consecutive slices, all N slices are scanned using an optical digital scanner, enabling for performing the MS measurements. Scanning the individual sections results into low-resolution images, which define the base coordinate system for the whole pipeline. The scanned images conclude the information from the spatial (MRI) and the mass spectrometric (MALDI-MSI) dimension and are used for the spatial three-dimensional reconstruction of the object performed by image registration techniques. Different strategies for automatic serial image registration applied to MS datasets are outlined in detail. The third image modality is histology driven, i.e. a digital scan of the histological stained slices in high-resolution. After fusion of reconstructed scan images and MRI the slice-related coordinates of the mass spectra can be propagated into 3D-space. After image registration of scan images and histological stained images, the anatomical information from histology is fused with the mass spectra from MALDI-MSI. As a result of the described pipeline we have a set of 3 dimensional images representing the same anatomies, i.e. the reconstructed slice scans, the spectral images as well as corresponding clustering results, and the acquired MRI. Great emphasis is put on the fact that the co-registered MRI providing anatomical details improves the interpretation of 3D MALDI images. The ability to relate mass spectrometry derived molecular information with in vivo and in vitro imaging has potentially important implications. This article is part of a Special Issue entitled: Computational Proteomics in the Post-Identification Era. Guest Editors: Martin Eisenacher and Christian Stephan.
Copyright © 2013. Published by Elsevier B.V.

Keywords:  Co-registration of image modalities; Data visualization; In vitro magnetic resonance imaging; MALDI mass spectrometry imaging; Serial registration; Spatial segmentation

Mesh:

Year:  2013        PMID: 23467008     DOI: 10.1016/j.bbapap.2013.01.040

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Feasibility Assessment of a MALDI FTICR Imaging Approach for the 3D Reconstruction of a Mouse Lung.

Authors:  E Ellen Jones; Cristine Quiason; Stephanie Dale; Sheerin K Shahidi-Latham
Journal:  J Am Soc Mass Spectrom       Date:  2017-04-11       Impact factor: 3.109

2.  Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.

Authors:  Walid M Abdelmoula; Michael S Regan; Begona G C Lopez; Elizabeth C Randall; Sean Lawler; Ann C Mladek; Michal O Nowicki; Bianca M Marin; Jeffrey N Agar; Kristin R Swanson; Tina Kapur; Jann N Sarkaria; William Wells; Nathalie Y R Agar
Journal:  Anal Chem       Date:  2019-04-22       Impact factor: 6.986

3.  Beyond the H&E: Advanced Technologies for in situ Tissue Biomarker Imaging.

Authors:  Lauren E Himmel; Troy A Hackett; Jessica L Moore; Wilson R Adams; Giju Thomas; Tatiana Novitskaya; Richard M Caprioli; Andries Zijlstra; Anita Mahadevan-Jansen; Kelli L Boyd
Journal:  ILAR J       Date:  2018-12-01

Review 4.  Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve.

Authors:  Peggi M Angel; H Scott Baldwin; Danielle Gottlieb Sen; Yan Ru Su; John E Mayer; David Bichell; Richard R Drake
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-03-21       Impact factor: 3.036

5.  Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues.

Authors:  Thomas W Powers; E Ellen Jones; Lucy R Betesh; Patrick R Romano; Peng Gao; John A Copland; Anand S Mehta; Richard R Drake
Journal:  Anal Chem       Date:  2013-10-03       Impact factor: 6.986

Review 6.  Unsupervised machine learning for exploratory data analysis in imaging mass spectrometry.

Authors:  Nico Verbeeck; Richard M Caprioli; Raf Van de Plas
Journal:  Mass Spectrom Rev       Date:  2019-10-11       Impact factor: 10.946

7.  Three-Dimensional Imaging with Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry.

Authors:  Hongxia Bai; Sitora Khodjaniyazova; Kenneth P Garrard; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2019-12-30       Impact factor: 3.109

8.  Advanced mass spectrometry technologies for the study of microbial pathogenesis.

Authors:  Jessica L Moore; Richard M Caprioli; Eric P Skaar
Journal:  Curr Opin Microbiol       Date:  2014-07-03       Impact factor: 7.934

Review 9.  Qualitative and quantitative mass spectrometry imaging of drugs and metabolites.

Authors:  Christopher B Lietz; Erin Gemperline; Lingjun Li
Journal:  Adv Drug Deliv Rev       Date:  2013-04-18       Impact factor: 15.470

Review 10.  Mass Spectrometry Imaging: A Review of Emerging Advancements and Future Insights.

Authors:  Amanda Rae Buchberger; Kellen DeLaney; Jillian Johnson; Lingjun Li
Journal:  Anal Chem       Date:  2017-12-13       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.